Gunnar Folprecht
机构: University hospital Carl Gustav Carus, University Cancer Center, Dresden, Germany
每年引用次数
引用次数
引用: 23,289
H-指数: 54
I10-指数 : 133
出版物: 399
Leukocytosis and neutrophilia as independent prognostic immunological biomarkers for clinical outcome in the CAO/ARO/AIO-04 randomized phase 3 rectal cancer trial.
Markus Diefenhardt , Ralf‐Dieter Hofheinz , Daniel Martin , Tim Beißbarth
International Journal of Cancer 145 ( 8) 2282 -2291
5
2019
Rituximab-induzierte rapide Tumorlyse bei therapierefraktärer B-ALL: übersicht und Fallbericht
F. Kroschinsky , C. Johne , J. Bergner , Dresden
Krankenhauspharmazie 23 ( 2) 53 -62
2002
Neue Therapieoptionen beim kolorektalen Karzinom
C.-H. Köhne , G. Folprecht
Therapeutische Umschau 61 ( 6) 373 -378
1
2004
Use of intratumoral mRNA expression of genes involved in angiogenesis and HIF1 pathway to predict outcome to VEGFR tyrosine kinase inhibitor (TKI) in patients enrolled in CONFIRM1 and CONFIRM2
P. M. Wilson , D. Yang , M. M. Shi , W. Zhang
Journal of Clinical Oncology 26 4002 -4002
11
2008
ERCC-1 gene expression levels and outcome to FOLFOX chemotherapy in patients enrolled in CONFIRM1 and CONFIRM2
H. J. Lenz , W. Zhang , M. M. Shi , C. Jacques
Journal of Clinical Oncology 26 4131 -4131
16
2008
Resectability and agreement between surgeons: Review of CT and MR scan of the CELIM study: (Multicenter randomized trial of cetuximab/FOLFOX versus cetuximab/FOLFIRI in unresectable liver metastases
W. O. Bechstein , H. Lang , C. Köhne , F. Parisi
Journal of Clinical Oncology 27 4091 -4091
6
2009
Cetuximab plus FOLFIRI first line in patients (pts) with metastatic colorectal cancer (mCRC): A quality-of-life (QoL) analysis of the CRYSTAL trial
G. Folprecht , M. Nowacki , I. Lang , S. Cascinu
Journal of Clinical Oncology 27 4076 -4076
7
2009
Aktuelle medikamentöse Therapie des metastasierten Kolonkarzinoms
G. Folprecht
Chirurg 81 ( 6) 507 -515
1
2010
Prinzipien der postoperativen Therapie beim Rektumkrazinom
G. Folprecht , C.-H. K�hne
Chirurg 75 ( 1) 32 -37
2
2004
Efficacy of bolus and infusional 5-FU in elderly and non-elderly patients with metastatic colorectal cancer - a pooled analysis of clinical trials
G. Folprecht , D. Cunningham , B. Glimelius , F. Dicostanzo
Journal of Clinical Oncology 22 8045 -8045
9
2004
Chemotherapy Plus Cetuximab in Patients with Colorectal Metastases Grouped by Site: A Pooled Analysis of the Crystal and OPUS Studies
C.-H. Köhne , C. Bokemeyer , G. Folprecht , U. Sartorius
Annals of Oncology 23 42 -42
2012
Dose escalating study of 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) and cetuximab in first-line therapy of patients with metastatic colorectal cancer
T. Trarbach , K. Schuette , J. Stoehlmacher , E. Goekkurt
Journal of Clinical Oncology 27
4
2009
Bevacizumab-induced changes in small arterial dilatation measured in vivo by dynamic retinal vessel analysis.
G. Folprecht , K. Trautmann , M. Reimann , R. Haase
Journal of Clinical Oncology 28 3575 -3575
2010
Cetuximab plus FOLFIRI: Final data from the CRYSTAL study on the association of KRAS and BRAF biomarker status with treatment outcome.
E. Van Cutsem , I. Lang , G. Folprecht , M. Nowacki
Journal of Clinical Oncology 28 3570 -3570
48
2010
P-79 C-PRECISE-01 study: A phase Ib/II trial of MEN1611, a PI3K inhibitor, and cetuximab in patients with PIK3CA mutated metastatic colorectal cancer failing irinotecan, oxaliplatin, 5-FU and anti-EGFR containing regimens
J. Tabernero , E. Elez Fernandez , F. Ghiringhelli , G. Folprecht
Annals of Oncology 31
2020
Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors
David F Heigener , Christian Schumann , Martin Sebastian , Parvis Sadjadian
Oncologist 20 ( 10) 1167 -1174
68
2015
3001 ORAL CRYSTAL, a randomized phase III trial of cetuximab plus FOLFIRI vs. FOLFIRI in first-line metastatic colorectal cancer (mCRC)
J.L. van Laethem , J.L. Raoul , F. Ciardiello , P. Lebrun
Ejc Supplements 5 ( 4) 235
30
2007
3558 POSTER Metastatic small bowel adenocarcinoma: favourable outcome in patients with primary tumour resected – retrospective analysis of 44 cases
A Kretzschmar , M Stahl , R Hofheinz , G Folprecht
Ejc Supplements 5 ( 4) 276 -277
2007
Chemotherapeutische Optionen bei Lebermetastasen
G. Folprecht , C.-H. Köhne
Visceral medicine 19 ( 4) 364 -369
2003
Diagnosis of and therapy for hepatocellular carcinoma
T. Greten , N. Malek , S. Schmidt , J. Arends
Zeitschrift Fur Gastroenterologie 51 ( 11) 1269 -1326
115
2013